Sign in

    Jerome Cambre

    Vice President of Sales at Viemed Healthcare Inc
    Since March 2018
    Age
    54 years
    Education
    Earned a Bachelor of Science Degree in Psychology from Louisiana State University and an Associate of Science Degree in Cardiopulmonary Science from Our Lady of the Lake College.
    Tenure
    Joined VMD as Vice President of Sales in March 2018 after holding roles as National Sales Trainer, Director of Clinical Sales, Patient Care Coordinator, and Sales Representative.

    Also at Viemed Healthcare Inc

    About

    Jerome Cambre has a well-rounded background in both education and professional service. He earned a Bachelor of Science Degree in Psychology from Louisiana State University and an Associate of Science Degree in Cardiopulmonary Science from Our Lady of the Lake College.

    He began his career at Sleep Management, LLC, serving in several capacities including Sales Representative (November 2013 to October 2015), Patient Care Coordinator (October 2015 to 2016), Director of Clinical Sales (March 2016 to March 2017), and National Sales Trainer (March 2017 to March 2018).

    In March 2018, he joined VMD as Vice President of Sales and has since contributed significantly to the development of the company’s sales strategies. As of Q1 2025, he is noted to be 54 years old , underscoring his extensive experience and ongoing impact at VMD.

    Past Roles

    Organization Role Date Range Details [N/A]
    VMD National Sales Trainer March 2017 - March 2018 N/A [N/A]
    Sleep Management, LLC Director of Clinical Sales March 2016 - March 2017 N/A [N/A]
    Sleep Management, LLC Patient Care Coordinator October 2015 - 2016 N/A [N/A]
    Sleep Management, LLC Sales Representative Starting November 2013 N/A [N/A]

    Fixed Compensation

    Data from  FY 2023
    Component NameAmount (USD)Payment ScheduleAdditional Details
    Salary$219,622 Annual 2023 Fixed base salary as per employment agreement
    Stock Awards$252,299 Granted in 2023 Aggregate grant date fair value of stock awards
    All Other Compensation$30,044 Annual 2023 Additional non-recurring compensation

    Performance Compensation

    Data from  FY 2023

    Bonus

    • Bonus Amount: $75,794
    • Details: Includes a corporation-wide active patient bonus and an additional sales bonus. Specific performance metrics, thresholds, targets, vesting schedules, and conditions are not provided.

    Nonequity Incentive Plan Compensation

    • Compensation Amount: $227,543
    • Details: Paid under the Cash Bonus Plan based on the Corporation's performance. No additional performance metrics, targets, or vesting conditions are available.

    Option-Based Awards

    • Value Vested: $293,237
    • Calculation Method: Based on the closing price of Common Shares on the vesting date. For CAD options, amounts are converted using the exchange rate on the grant date.
    • Outstanding Awards (Key Details):
      • Grant Dates: January 4, 2018; January 17, 2019; January 17, 2020; January 21, 2021; January 18, 2022
      • Option Exercise Prices: $1.81, $4.13, $5.70, $8.57, $5.21 respectively
      • Expiration Dates: January 4, 2028; January 17, 2029; January 17, 2030; January 21, 2031; January 18, 2032 respectively
      • Aggregate Intrinsic Values: $810,363; $1,137,583; $497,082; $0; $335,370 respectively
    • Additional Detail: A grant under the 2020 LTIP provided a grant date fair value of $201,275.
    • Vesting Conditions: Vesting schedules and performance events are specified in the respective award agreements, but further details on performance metrics or targets are not provided.

    Share-Based Awards

    • Value Vested during 2023: $81,165
    • Plan: Phantom Share Plan with awards granted having a grant date fair value of $51,024.
    • Vesting Conditions: Awards may vest immediately or per a vesting schedule/performance event with cash payments within 60 days of vesting. Specific performance targets and metrics are not disclosed.
    • Grant Date Stock Price: The weighted average fair value at vesting was $8.27.

    No additional detailed performance metrics (e.g., thresholds, target percentages, weights, or evaluation periods) are provided in the documents for any of these performance compensation components.